Recombinant Human LST1 Protein，His

LST1 (Leukocyte-specific transcript 1) is a member of the interferon-inducible GTPase family, primarily expressed in immune cells, particularly lymphocytes and macrophages. Its role in the immune response has been of significant interest, especially concerning its involvement in regulating inflammation, cell signaling, and pathogen defense mechanisms. Research has suggested that LST1 may be implicated in various disease processes, including autoimmune disorders and infections. The recombinant expression of LST1 protein allows for a detailed examination of its functional properties, facilitating studies on its structure-function relationship and potential therapeutic applications. Understanding the molecular mechanisms by which LST1 operates could lead to novel insights into the modulation of immune responses and the development of targeted therapies for immune-related diseases. Moreover, the production of LST1 protein in a recombinant form is crucial for biochemical assays, further elucidating its role in immune regulation and providing a platform for drug development and vaccine research. As such, the study of LST1 not only enhances the current knowledge of immune system functioning but also holds promise for advances in clinical applications.